They indeed confirmed this hypothesis by studying the effects of P38 pharmacological inhibition on cell growth in the EGFR mutant (delE746_A750) adenocarcinoma cell line (HCC827), which is derived from never smokers that do not harbour the KRAS mutation. The gene discussed is EGFR; the disease is adenocarcinoma.